PROCEPT BioRobotics (PRCT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $17.57, -3.20% vs the prior close of $18.15.
- Volume 1.20M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PRCT slides 3.2% to $17.57. Closed at $17.57, -3.20% vs the prior close of $18.15. Day range $17.53–$18.67, opened at $18.36.
PRCT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PRCT slides 3.2% to $17.57
- Closed at $17.57, -3.20% vs the prior close of $18.15. Day range $17.53–$18.67, opened at $18.36.
- Volume was 1.20M shares, 0.9x its 50-day average of 1.29M.
- Price is -11.3% vs its 50-day average ($19.81) and -26.7% vs its 200-day average ($23.97).
- 52-week range $16.67–$38.11; today's close sits at 4% of that range, 53.9% below the 52-week high.
Oct 15, 2026 — PRCT jumps 3.7% to $18.15
- Closed at $18.15, +3.66% vs the prior close of $17.51. Day range $17.58–$18.23, opened at $17.58.
- Volume was 1.25M shares, 0.9x its 50-day average of 1.37M.
- Price is -8.6% vs its 50-day average ($19.85) and -24.5% vs its 200-day average ($24.04).
- 52-week range $16.67–$38.11; today's close sits at 7% of that range, 52.4% below the 52-week high.
Oct 14, 2026 — PRCT slides 8.3% to $17.51
- Closed at $17.51, -8.32% vs the prior close of $19.10. Day range $17.49–$19.02, opened at $19.00.
- Volume was 1.73M shares, 1.2x its 50-day average of 1.41M.
- Price is -11.9% vs its 50-day average ($19.88) and -27.4% vs its 200-day average ($24.11).
- 52-week range $16.67–$38.11; today's close sits at 4% of that range, 54.1% below the 52-week high.
Oct 13, 2026 — PRCT dips 2.4% to $19.10
- Closed at $19.10, -2.40% vs the prior close of $19.57. Day range $18.68–$19.87, opened at $19.73.
- Volume was 1.81M shares, 1.3x its 50-day average of 1.43M.
- Price is -4.0% vs its 50-day average ($19.89) and -21.0% vs its 200-day average ($24.19).
- 52-week range $16.67–$38.11; today's close sits at 11% of that range, 49.9% below the 52-week high.
Oct 12, 2026 — PRCT jumps 6.4% to $19.57
- Closed at $19.57, +6.36% vs the prior close of $18.40. Day range $18.46–$19.80, opened at $18.48.
- Volume was 2.05M shares, 1.4x its 50-day average of 1.42M.
- Price is -1.6% vs its 50-day average ($19.88) and -19.3% vs its 200-day average ($24.25).
- 52-week range $16.67–$38.11; today's close sits at 14% of that range, 48.6% below the 52-week high.
Oct 9, 2026 — PRCT rises 2.8% to $18.40
- Closed at $18.40, +2.79% vs the prior close of $17.90. Day range $17.78–$18.44, opened at $17.78.
- Volume was 1.11M shares, 0.8x its 50-day average of 1.42M.
- Price is -7.4% vs its 50-day average ($19.86) and -24.3% vs its 200-day average ($24.32).
- 52-week range $16.67–$38.11; today's close sits at 8% of that range, 51.7% below the 52-week high.
Oct 8, 2026 — PRCT ends flat (-0.1%) to $17.90
- Closed at $17.90, -0.06% vs the prior close of $17.91. Day range $17.52–$18.03, opened at $17.80.
- Volume was 1.18M shares, 0.8x its 50-day average of 1.41M.
- Price is -9.8% vs its 50-day average ($19.85) and -26.6% vs its 200-day average ($24.40).
- 52-week range $16.67–$38.11; today's close sits at 6% of that range, 53.0% below the 52-week high.
Oct 7, 2026 — PRCT rises 2.3% to $17.91
- Closed at $17.91, +2.28% vs the prior close of $17.51. Day range $17.63–$18.46, opened at $17.63.
- Volume was 1.15M shares, 0.8x its 50-day average of 1.42M.
- Price is -9.8% vs its 50-day average ($19.85) and -26.8% vs its 200-day average ($24.47).
- 52-week range $16.67–$38.11; today's close sits at 6% of that range, 53.0% below the 52-week high.
Oct 6, 2026 — PRCT dips 1.7% to $17.51
- Closed at $17.51, -1.74% vs the prior close of $17.82. Day range $17.22–$18.00, opened at $17.82.
- Volume was 949.30K shares, 0.7x its 50-day average of 1.43M.
- Price is -11.8% vs its 50-day average ($19.86) and -28.7% vs its 200-day average ($24.54).
- 52-week range $16.67–$38.11; today's close sits at 4% of that range, 54.1% below the 52-week high.
Oct 5, 2026 — PRCT jumps 3.8% to $17.82
- Closed at $17.82, +3.85% vs the prior close of $17.16. Day range $17.12–$18.09, opened at $17.16.
- Volume was 971.00K shares, 0.7x its 50-day average of 1.45M.
- Price is -10.3% vs its 50-day average ($19.86) and -27.6% vs its 200-day average ($24.63).
- 52-week range $16.67–$38.11; today's close sits at 5% of that range, 53.2% below the 52-week high.
Oct 2, 2026 — PRCT rises 0.8% to $17.16
- Closed at $17.16, +0.82% vs the prior close of $17.02. Day range $16.95–$17.91, opened at $17.19.
- Volume was 1.24M shares, 0.9x its 50-day average of 1.45M.
- Price is -13.5% vs its 50-day average ($19.84) and -30.6% vs its 200-day average ($24.72).
- 52-week range $16.67–$38.11; today's close sits at 2% of that range, 55.0% below the 52-week high.
- SEC filings that day: 8-K.
PRCT latest news & SEC filings
Every SEC filing by or about PRCT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mack Michael received an award of 7,727 shares on Oct 2, 2026; now holds 7,727
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Nouri Alaleh sold 297 shares at $20.95 (≈$6.22K) on Sep 9, 2026
- Nouri Alaleh sold 297 shares at $20.95 (≈$6.22K) on Sep 9, 2026
- Nouri Alaleh sold 297 shares at $20.95 (≈$6.22K) on Sep 9, 2026
- Nouri Alaleh sold 297 shares at $20.95 (≈$6.22K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Templin Barry L sold 373 shares at $20.95 (≈$7.81K) on Sep 9, 2026
- Templin Barry L sold 373 shares at $20.95 (≈$7.81K) on Sep 9, 2026
- Templin Barry L sold 373 shares at $20.95 (≈$7.81K) on Sep 9, 2026
- Templin Barry L sold 373 shares at $20.95 (≈$7.81K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Waters Kevin sold 373 shares at $20.95 (≈$7.81K) on Sep 9, 2026
- Waters Kevin sold 373 shares at $20.95 (≈$7.81K) on Sep 9, 2026
- Waters Kevin sold 373 shares at $20.95 (≈$7.81K) on Sep 9, 2026
- Waters Kevin sold 373 shares at $20.95 (≈$7.81K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 9, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $94.50M (prior year $79.18M) (+19.3% vs Jun 30, 2025)
- Net income: -$26.86M (prior year -$19.58M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.47 (prior year -$0.35) (loss widened vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade PRCT
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: Apr 29, 2026, Feb 25, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.97% (largest 8.3%).
- Liquidity: about 1.41M shares (≈$24.84M) trade per day on average.
- 52-week position: $17.57 vs a range of $16.67–$38.11 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 21 sales; latest: Kevin Waters sold 373 shares on Sep 9, 2026.
- Latest filings: 8-K Oct 2, 2026; 8-K Sep 24, 2026; 10-Q Aug 5, 2026.
- Share count: 57.27M shares outstanding (Jul 31, 2026), +2.9% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
PRCT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 18.36 | 18.67 | 17.53 | 17.57 | 1.20M |
| Oct 15, 2026 | 17.58 | 18.23 | 17.58 | 18.15 | 1.25M |
| Oct 14, 2026 | 19.00 | 19.02 | 17.49 | 17.51 | 1.73M |
| Oct 13, 2026 | 19.73 | 19.87 | 18.68 | 19.10 | 1.81M |
| Oct 12, 2026 | 18.48 | 19.80 | 18.46 | 19.57 | 2.05M |
| Oct 9, 2026 | 17.78 | 18.44 | 17.78 | 18.40 | 1.11M |
| Oct 8, 2026 | 17.80 | 18.03 | 17.52 | 17.90 | 1.18M |
| Oct 7, 2026 | 17.63 | 18.46 | 17.63 | 17.91 | 1.15M |
| Oct 6, 2026 | 17.82 | 18.00 | 17.22 | 17.51 | 949.30K |
| Oct 5, 2026 | 17.16 | 18.09 | 17.12 | 17.82 | 971.00K |
| Oct 2, 2026 | 17.19 | 17.91 | 16.95 | 17.16 | 1.24M |
| Oct 1, 2026 | 18.26 | 18.46 | 16.74 | 17.02 | 1.60M |
| Sep 30, 2026 | 18.09 | 18.50 | 17.68 | 18.22 | 1.59M |
| Sep 29, 2026 | 17.37 | 18.67 | 16.80 | 18.22 | 2.19M |
| Sep 28, 2026 | 17.23 | 17.46 | 16.80 | 17.25 | 1.75M |
| Sep 25, 2026 | 17.37 | 17.69 | 17.05 | 17.20 | 1.95M |
| Sep 24, 2026 | 18.22 | 18.40 | 17.25 | 17.50 | 1.35M |
| Sep 23, 2026 | 18.34 | 18.62 | 17.94 | 18.09 | 914.70K |
| Sep 22, 2026 | 18.87 | 19.20 | 18.40 | 18.43 | 1.17M |
| Sep 21, 2026 | 19.31 | 19.38 | 18.41 | 18.51 | 1.11M |
About PROCEPT BioRobotics
PROCEPT BioRobotics (PRCT) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SAN JOSE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1588978.
PRCT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Antal Rohit Desai | Director | Jun 10, 2026 |
| Amy M. Dodrill | Director | Jun 10, 2026 |
| Mary Garrett | Director | Jun 10, 2026 |
| Taylor C. Harris | Director | Jun 10, 2026 |
| Elisabeth Sandoval Little | Director | Jun 10, 2026 |
| Frederic H Moll | Director | Jun 10, 2026 |
| Thomas M Prescott | Director | Jun 10, 2026 |
| Dan Puckett | Director | Jun 10, 2026 |
| Larry L Wood | President, CEO | Aug 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Alaleh Nouri | EVP, CLO, CORP. SEC. | Sep 10, 2026 |
| Pooja Sharma | Chief Strat/Marketing Officer | Aug 14, 2026 |
| Barry L Templin | EVP, Chief Technology Officer | Sep 10, 2026 |
| Kevin Waters | EVP, CFO | Sep 10, 2026 |
| Larry L Wood | President, CEO | Aug 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 9, 2026 | Kevin Waters | Sale | 373 | $20.95 |
| Sep 9, 2026 | Kevin Waters | Sale | 373 | $20.95 |
| Sep 9, 2026 | Kevin Waters | Sale | 373 | $20.95 |
| Sep 9, 2026 | Kevin Waters | Sale | 373 | $20.95 |
| Sep 9, 2026 | Alaleh Nouri | Sale | 297 | $20.95 |
| Sep 9, 2026 | Alaleh Nouri | Sale | 297 | $20.95 |
| Sep 9, 2026 | Alaleh Nouri | Sale | 297 | $20.95 |
| Sep 9, 2026 | Alaleh Nouri | Sale | 297 | $20.95 |
| Sep 9, 2026 | Barry L Templin | Sale | 373 | $20.95 |
| Sep 9, 2026 | Barry L Templin | Sale | 373 | $20.95 |
| Sep 9, 2026 | Barry L Templin | Sale | 373 | $20.95 |
| Sep 9, 2026 | Barry L Templin | Sale | 373 | $20.95 |
| Aug 7, 2026 | Larry L Wood | Buy | 23,900 | $20.85 |
| Aug 7, 2026 | Larry L Wood | Buy | 23,900 | $20.85 |
| Aug 7, 2026 | Larry L Wood | Buy | 23,900 | $20.85 |
PRCT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $308.05M | $-95.57M | -1.72 | $-48.98M |
| Dec 31, 2024 | $224.50M | $-91.41M | -1.75 | $-99.21M |
| Dec 31, 2023 | $136.19M | $-105.90M | -2.24 | $-108.00M |
| Dec 31, 2022 | $75.01M | $-87.15M | -1.96 | $-80.38M |
| Dec 31, 2021 | $34.47M | $-59.85M | -3.63 | $-57.33M |
Latest balance sheet: total assets $479.35M, total liabilities $139.28M, cash $227.91M (as of Jun 30, 2026).
PRCT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $18.28 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $21.71 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $27.84 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $35.02 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $45.69 |
| Jul 25, 2025 | 8-K Item 2.02 (results) | $55.72 |
| Apr 24, 2025 | 8-K Item 2.02 (results) | $52.56 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $62.71 |
| Oct 28, 2024 | 8-K Item 2.02 (results) | $91.00 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PRCT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.